Literature DB >> 1615984

Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis.

B M Sibai1, C Sarinoglu, B M Mercer.   

Abstract

OBJECTIVES: Our goal was to report pregnancy outcome and long-term prognosis after eclampsia. STUDY
DESIGN: Women whose pregnancies were managed at the E.H. Crump Women's Hospital between August 1977 and April 1989 were studied. A total of 223 women with eclampsia underwent follow-up for an average of 7.2 years. Thirteen had preexisting hypertension and 210 were normotensive (31 were multiparous and 179 were nulliparous).
RESULTS: Among these women 23 who were multiparous and 159 who were nulliparous had 366 subsequent pregnancies: 22% of pregnancies were complicated by preeclampsia, 1.9% by eclampsia, and 2.5% by abruptio placentae; 2.7% resulted in perinatal death. Within the nulliparous group, women who had eclampsia before 37 weeks' gestation in the index pregnancy had significantly higher incidences of preeclampsia and poor perinatal outcome in subsequent pregnancies as compared with those who had eclampsia at greater than or equal to 37 weeks' gestation; the highest incidence of obstetric complications occurred in those having eclampsia at less than or equal to 30 weeks. Twenty of the 210 normotensive women (9.5%) had chronic hypertension on follow-up; the highest incidence (17.9%) being in those with eclampsia at less than or equal to 30 weeks and the lowest incidence (4.8%) in those having eclampsia at greater than or equal to 37 weeks. Women with eclampsia who had preeclampsia in subsequent pregnancies had a higher incidence of chronic hypertension as compared with those who were normotensive in subsequent pregnancies (25% vs 2%, p less than 0.0001). Long-term maternal complications included dialysis required in one patient and one case of cardiomyopathy in women with chronic hypertension; there was one maternal death in a women with chronic hypertension. None of the women had evidence of neurologic deficit or seizures during follow-up.
CONCLUSIONS: These findings should be used in counseling women who have had eclampsia and are considering future pregnancies.

Entities:  

Mesh:

Year:  1992        PMID: 1615984     DOI: 10.1016/0002-9378(92)91566-s

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  17 in total

Review 1.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

Review 2.  Pre-eclampsia and long-term maternal health.

Authors:  David Williams
Journal:  Obstet Med       Date:  2012-08-20

Review 3.  The management of pregnancy in hypertensive patients.

Authors:  R D Tunbridge
Journal:  Postgrad Med J       Date:  1994-11       Impact factor: 2.401

4.  Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study.

Authors:  Brenda J Wilson; M Stuart Watson; Gordon J Prescott; Sarah Sunderland; Doris M Campbell; Philip Hannaford; W Cairns S Smith
Journal:  BMJ       Date:  2003-04-19

5.  Cardiovascular sequelae of toxaemia of pregnancy.

Authors:  P Hannaford; S Ferry; S Hirsch
Journal:  Heart       Date:  1997-02       Impact factor: 5.994

6.  Hypertension in pregnancy: new recommendations for management.

Authors:  R Shear; L Leduc; E Rey; J M Moutquin
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

7.  Could alterations in maternal plasma visfatin concentration participate in the phenotype definition of preeclampsia and SGA?

Authors:  Shali Mazaki-Tovi; Roberto Romero; Sun Kwon Kim; Edi Vaisbuch; Juan Pedro Kusanovic; Offer Erez; Tinnakorn Chaiworapongsa; Francesca Gotsch; Pooja Mittal; Chia-Ling Nhan-Chang; Nandor Gabor Than; Ricardo Gomez; Jyh Kae Nien; Samuel S Edwin; Percy Pacora; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-08

8.  Retinol binding protein 4--a novel association with early-onset preeclampsia.

Authors:  Edi Vaisbuch; Roberto Romero; Shali Mazaki-Tovi; Offer Erez; Sun Kwon Kim; Tinnakorn Chaiworapongsa; Francesca Gotsch; Nandor Gabor Than; Zhong Dong; Percy Pacora; Ronald Lamont; Lami Yeo; Sonia S Hassan; Juan Pedro Kusanovic
Journal:  J Perinat Med       Date:  2010-03       Impact factor: 1.901

9.  Adiponectin in severe preeclampsia.

Authors:  Jyh Kae Nien; Shali Mazaki-Tovi; Roberto Romero; Offer Erez; Juan Pedro Kusanovic; Francesca Gotsch; Beth L Pineles; Ricardo Gomez; Samuel Edwin; Moshe Mazor; Jimmy Espinoza; Bo Hyun Yoon; Sonia S Hassan
Journal:  J Perinat Med       Date:  2007       Impact factor: 1.901

10.  Maternal serum adiponectin multimers in preeclampsia.

Authors:  Shali Mazaki-Tovi; Roberto Romero; Edi Vaisbuch; Juan Pedro Kusanovic; Offer Erez; Francesca Gotsch; Tinnakorn Chaiworapongsa; Nandor Gabor Than; Sun Kwon Kim; Chia-Ling Nhan-Chang; Cristiano Jodicke; Percy Pacora; Lami Yeo; Zhong Dong; Bo Hyun Yoon; Sonia S Hassan; Pooja Mittal
Journal:  J Perinat Med       Date:  2009       Impact factor: 1.901

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.